Mometason Glenmark (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Glenmark, is a corticosteroid (glucocorticoid) presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions affecting adults and children. The medication is formulated for external use and is indicated for short‑term therapy under medical supervision.

GNH USA supplies Mometason Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Mometasone furoate is a topical corticosteroid that reduces inflammation in several skin disorders.

- Psoriasis: alleviates plaque formation and erythema, improving skin appearance. - Atopic dermatitis: decreases itching and inflammation, helping restore barrier function. - Eczema: reduces redness and scaling, providing symptomatic relief. - Contact dermatitis: mitigates allergic skin reactions and swelling.

Topical application of mometasone furoate may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site - Pruritus or mild itching - Dryness or flaking of the skin

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use - Telangiectasia or visible small blood vessels - Hypothalamic‑pituitary‑adrenal axis suppression leading to systemic corticosteroid effects

When using Mometason Glenmark, several precautions should be observed to minimize risks.

- Apply only to intact skin: avoid open wounds or infected areas. - Limit treatment duration: typically no longer than 2‑4 weeks unless directed by a physician. - Do not use under occlusive dressings: may increase absorption and side effects. - Avoid use on large body surface areas in children: higher systemic exposure risk. - Monitor for signs of infection: discontinue if worsening or secondary infection occurs. - Store at room temperature: keep in original container, protect from moisture and light.

Mometasone furoate can interact with other agents that affect corticosteroid metabolism or enhance systemic exposure.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise systemic levels of mometasone.

Moderate Interactions (Monitor Closely): - Antiviral or antifungal topical agents: potential additive skin irritation. - Live attenuated vaccines: topical steroids may reduce local immune response, consider timing.